Walgreens Boots Alliance (WBA) unveiled a definitive agreement late Thursday to be acquired by an entity affiliated with Sycamore Partners for up to $23.7 billion.
The price tag is based on a cash consideration of $11.45 per share and up to $3 per divested-asset-proceed right, plus net debt, capital leases, present value of opioid liability, and a settlement, Walgreens said. Walgreens will become a private entity and its shares will crease to trade on Nasdaq upon deal close.
The cash consideration represents a 29% premium, and the total consideration represents a premium of up to 63% to Walgreens closing share price of $8.85 as of Dec. 9, the day before media reported the deal.
The transaction has been approved by Walgreens' board and is expected to close in Q4, subject to certain approvals and customary conditions.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.